6th Pharma Pricing and Reimbursement Forum
Online
Key Takeaways The latest outcomes of the effects of COVID19 on the delay of new product launch Can Price Transparency contribute to more affordable patient access to medicines? Reaching a better integration of regulatory pathways A look into the personalized reimbursement system Early Payer Engagement Equal access and multi-indication medicines
Details
Costs: n/a
Event type: Corporate events
Registration information: n/a
Posted by: Krashan Gsekar
Other events you might be interested in:
